What Is Spinal Cord Injury?

Spinal cord injury (SCI) is damage to the spinal cord that causes partial or complete loss of motor function, sensation, or autonomic control below the level of the injury. SCI is classified as complete, when no motor or sensory function is preserved below the lesion, or incomplete, when some function remains. The American Spinal Injury Association (ASIA) impairment scale provides the standard clinical grading from ASIA A (complete) through ASIA E (normal function). SCI ranks among the most consequential forms of neurological trauma, affecting an estimated 250,000 to 500,000 people worldwide each year, and it shares pathological mechanisms with several progressive neurological diseases, including multiple sclerosis and amyotrophic lateral sclerosis, in that axonal degeneration and loss of myelin insulation disrupt neural conduction along the same long tracts of the cord.

Pathophysiology

Spinal cord injury unfolds in two phases. The primary injury results from the immediate mechanical event, whether vertebral fracture, dislocation, or penetrating trauma, which ruptures blood vessels, destroys cell membranes, and causes direct necrosis of neurons and glia in the affected segments. The secondary injury phase follows over hours to weeks and involves a cascade of biochemical events: ischemia from disrupted vasculature, excitotoxicity from excess glutamate release, oxidative stress from reactive oxygen species, and inflammation driven by infiltrating immune cells. The injury site is eventually replaced by a glial scar composed largely of reactive astrocytes, which creates a physical and chemical barrier that inhibits axonal regeneration. Understanding this cascade has shaped pharmacological trials targeting inflammation and oxidative damage, though no intervention has yet achieved robust axonal regrowth across a complete lesion in clinical practice.

Neural Repair and Stimulation

Epidural spinal cord stimulation (eSCS) has emerged as one of the most clinically significant tools for restoring function after SCI. Electrode arrays placed on the dorsal surface of the cord deliver continuous or patterned electrical pulses that activate local sensorimotor circuits and amplify residual descending signals from the brain. Clinical trials have demonstrated that epidural electrical stimulation can restore voluntary leg movement in individuals classified as motor-complete, a result that fundamentally revised assumptions about the permanence of complete SCI. Stimulation is typically combined with intensive locomotor rehabilitation, and the combination appears to drive neuroplastic remodeling in residual spared pathways. Transcutaneous stimulation, which applies current non-invasively through surface electrodes on the skin over the spine, is under development as a less invasive alternative. Tissue engineering approaches use biomaterial scaffolds and cell transplantation to bridge lesion cavities and create a permissive environment for regrowing axons, while gene therapy vectors are being explored to suppress inhibitory signals from the glial scar.

Neural Interface Technologies

Beyond stimulation, SCI has driven substantial engineering work on neural interfaces that bypass the lesion entirely. Brain-computer interfaces record motor cortex signals and decode intended limb movements, relaying those commands to functional electrical stimulation systems that activate paralyzed muscles. Closed-loop systems incorporate sensory feedback from limb sensors to modulate stimulation in real time. Case studies published in Nature Communications have demonstrated that percutaneous epidural stimulation combined with decoded cortical commands can enable voluntary motor control in individuals years after injury. Robotic exoskeletons controlled by residual voluntary movement offer a parallel approach that provides weight-bearing mobility without implanted hardware.

Applications

Spinal cord injury research and technology development have applications in several clinical and engineering domains, including:

• Epidural and transcutaneous stimulation systems for restoring motor and autonomic function
• Brain-spinal interfaces for bypassing incomplete lesions
• Robotic exoskeletons and powered orthotics for rehabilitation
• Biomaterial scaffolds for axon regeneration across injury sites
• Neuroprotective drug therapies targeting the secondary injury cascade